Development of a small-molecule based CD47 Immune Checkpoint inhibitor for the treatment of cancer patients | RVO.nl | Rijksdienst

Service menu right

Development of a small-molecule based CD47 Immune Checkpoint inhibitor for the treatment of cancer patients